My bookmarksSign up free
Source

Commission Implementing Regulation (EU) 2026/2083 of 18 September 2026 on MyHealth@EU

Commission Implementing Regulation (EU) 2026/2083 of 18 September 2026 on MyHealth@EU

Implementing Regulation (EU) 2026/2083 · Regulation · 19 articles

In force

Version historyWe hold this version only; in force from 2026-09-18.

Data as of 2026-10-15 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Subject matter and scope

Article 1

Open ↗

1.   This Regulation lays down the rules regarding the requirements of cybersecurity, technical interoperability, semantic interoperability, operations and service management in relation to the processing by the Commission as processor for MyHealth@EU and its responsibilities towards the joint controllers. It provides the necessary measures for the technical development of MyHealth@EU, detailed rules concerning the security, confidentiality and protection of personal electronic health data and the conditions for compliance checks necessary to join and remain connected to MyHealth@EU. 2.   Article 7, except for paragraph 1, point (a), and Articles 8 to 13 shall apply mutatis mutandis to authorised participants referred to in Article 24(2) and (3) of Regulation (EU) 2025/327. Compliance checks and technical tests for such authorised participants may also cover additional requirements relevant for them.

Definitions

Article 2

Open ↗

For the purposes of this Regulation the following definitions shall apply: 1. ‘steering group’ means the MyHealth@EU steering group established by Article 95(1) of Regulation (EU) 2025/327 for the cross-border infrastructure provided for in Article 23 of that Regulation; 2. ‘major release’ means a version of the requirements catalogue and technical specifications that is not backwards compatible with the preceding version or has a substantial impact on the exchange of personal electronic health data through MyHealth@EU; 3. ‘minor release’ means a version of the requirements catalogue and technical specifications and their implementation that is not a major release; 4. the definition of ‘incident’ laid down in Article 6, point (6), of Directive (EU) 2022/2555 of the European Parliament and of the Council  ( 8 ) ; 5. ‘significant incident’ means an incident as referred to in Article 23(3) of Directive (EU) 2022/2555.

Central interoperability platform for digital health

Article 3

Open ↗

1.   The Commission shall provide the following services of the central interoperability platform for digital health referred to in Article 23(1) of Regulation (EU) 2025/327: (a) a reference implementation software for national contact points for digital health; (b) a central terminology service; (c) a secure communication network; (d) a central configuration service. 2.   The Commission shall provide the services referred to in paragraph 1 in accordance with the requirements catalogue referred to in Article 4(2), and the technical specifications referred to in Article 4(3). 3.   National contact points for digital health may use the reference implementation referred to in paragraph 1, point (a), to support the exchange of personal electronic health data in MyHealth@EU. Where a national contact point for digital health chooses to use alternative solutions, these shall be compliant with the requirements catalogue referred to in Article 4(2), and the technical specifications referred to in Article 4(3). 4.   National contact points for digital health may use the central terminology service referred to in paragraph 1, point (b), to support the translation and mapping of the coding systems and values to be used in datasets containing personal electronic health data as referred to in Article 15(1), first subparagraph, point (b), of Regulation (EU) 2025/327. 5.   Member States shall be responsible for the translation and mapping of coding systems and value sets for the exchange personal electronic health data, in the European electronic health record exchange format referred to in Article 15(1) of Regulation (EU) 2025/327. Member States shall keep the translations and mappings up to date. 6.   National contact points for digital health shall use the secure communication network referred to in paragraph 1, point (c), to support the exchange of personal electronic health data between national contact points for digital health. The operation of national infrastructures and national services supporting the secure communication network shall remain the responsibility of national contact points for digital health. 7.   National contact points for digital health shall use the central configuration service referred to in paragraph 1, point (d), to make their configuration details available to the Commission and to all other national contact points for digital health.

Requirements catalogue and technical specifications

Article 4

Open ↗

1.   Where national contact points for digital health perform cross-border exchanges of personal electronic health data referred to in Article 23(3) of Regulation (EU) 2025/327, they shall perform it in accordance with the requirements catalogue referred to in paragraph 2 and the technical specifications referred to in paragraph 3. 2.   The Commission, in cooperation with the steering group, shall draw up and maintain the requirements catalogue for the cross-border exchange of personal electronic health data in MyHealth@EU. That requirements catalogue shall include at least: (a) a description of the use cases implemented for the exchange of personal electronic health data; (b) requirements for the implementation of the exchange of personal electronic health data; (c) frameworks and procedures for the testing, compliance checking, operation, and monitoring of incidents of the exchange of personal electronic health data. 3.   The Commission, in cooperation with the steering group, shall propose the technical specifications based on the requirements catalogue referred to in paragraph 2. 4.   The requirements catalogue referred to in paragraph 2 and the technical specifications referred to in paragraph 3 shall be approved by the steering group.

Operations and management of MyHealth@EU

Article 5

Open ↗

1.   The Commission, in cooperation with the steering group, shall perform the following activities for the operations and management of MyHealth@EU: (a) elicitation, analysis, and management of requirements and technical specifications; (b) coordination of development, testing, and deployment; (c) changes to the requirements catalogue; (d) incident management; (e) ensuring business continuity of the platform. 2.   The Commission shall perform the following tasks: (a) conduct technical tests of the cross-border exchange of personal electronic health data; (b) provide support to the service desks of national contact points for digital health or authorised participants. 3.   The Commission, in cooperation with the steering group, shall propose an annual work plan for the activities referred to in paragraphs 1 and 2, for approval by the steering group.

Changes to the requirements catalogue

Article 6

Open ↗

1.   Upon request by five or more members of the steering group or on its own initiative, the Commission may submit to the steering group a proposal for a major change to the requirements catalogue. The change proposal shall include at least: (a) a description of the changes; (b) a justification for the changes; (c) a timeline for implementation of the changes; (d) a major release to address the proposed changes. 2.   The steering group shall be responsible for approving the changes to the requirements catalogue referred to in Article 4(2), the timeline for the implementation of the changes and the major release. 3.   Once the changes referred to in paragraph 2 are approved, the Commission, national contact points for digital health and authorised participants shall implement them in accordance with the approved implementation timeline and major release. 4.   A minor release shall not be subject to the submission of a change proposal. The Commission may submit a change for a minor release to the steering group. Where such a change is submitted, the steering group shall, upon receipt, be responsible for approving the proposal for a minor release, including its implementation timeline. Once the minor release is approved, the Commission, national contact points for digital health and authorised participants shall implement it in accordance with the approved implementation timeline.

Managing authorisation for cross-border exchange of personal electronic health data

Article 7

Open ↗

1.   The Commission shall, on behalf of the steering group, be responsible for managing the procedures for authorising the exchange of personal electronic health data. They shall be the following: (a) authorising a national contact point for digital health to start the exchange of personal electronic health data; (b) authorising a national contact point for digital health or an authorised participant to continue the exchange of personal electronic health data after an upgrade to the latest major release; (c) authorising a national contact point for digital health or an authorised participant to continue the exchange of personal electronic health data after an operational compliance check referred to in Article 9, point b; (d) addressing significant incidents in the exchange of personal electronic health data. 2.   The Commission, in collaboration with the steering group, shall propose the methodology for the procedures on authorisations referred to in paragraph 1, for approval by the steering group. 3.   The steering group shall decide whether or not to grant an authorisation referred to in paragraph 1, points (a), (b) or (c) on the basis of the requirements laid down in Articles 10 to 12. 4.   Where the steering group decides not to grant an authorisation provided for in paragraph 1, the national contact point for digital health may request the steering group to review its decision.

Conditions for joining and remaining connected to MyHealth@EU, compliance checks and technical tests

Article 8

Open ↗

1.   The Commission shall conduct compliance checks and facilitate technical tests to assess the compliance of the exchange of personal electronic health data between national contact points for digital health with the requirements catalogue referred to in Article 4(2) and the technical specifications referred to in Article 4(3). 2.   A compliance check shall identify findings on security, confidentiality and protection of the exchange of personal electronic health data through MyHealth@EU. Findings shall be categorised as ‘minor’, ‘medium’ or ‘critical’ depending on the levels of compliance as defined in the compliance check framework referred to in Article 4(2), point (c). 3.   A technical test shall assess the cross-border exchange of personal electronic health data between national contact points for digital health through MyHealth@EU and their conformance with the technical specifications referred to in Article 4(3). Findings shall be categorised as ‘minor’, ‘medium’ or ‘critical’ depending on the levels of compliance as defined in the test framework referred to in Article 4(2), point (c). 4.   The Commission shall inform the national contact points for digital health of the results of the compliance checks and technical tests referred to in paragraph 1. This information shall contain, as a minimum, findings, observations and recommendations based on the results of the compliance checks and technical tests. 5.   Where a compliance check or technical test has identified findings, regardless of their level, the national contact point for digital health concerned shall take measures to close findings after receiving information on the outcome of the compliance check or technical test from the Commission. An action plan containing measures to address the identified findings shall be submitted to the Commission within 15 working days of receipt of information on the findings. 6.   After an action plan has been implemented, the national contact point for digital health shall notify the Commission. The Commission shall then assess the relevant evidence and decide to close any of the addressed findings. 7.   The Commission shall regularly communicate open findings from compliance checks and technical tests to the steering group.

Frequency of compliance checks

Article 9

Open ↗

The Commission shall assess the compliance of the exchange of personal electronic health data with the requirements catalogue referred to in Article 4(2) and the technical specifications referred to in Article 4(3): (a) before the start of the exchange of personal electronic health data; (b) every five years after the latest compliance check; (c) where the Commission considers that there is a critical risk to the security, confidentiality or protection of personal electronic health data.

Authorisation to start the exchange of personal electronic health data

Article 10

Open ↗

A national contact point for digital health shall obtain authorisation referred to in Article 7(1), point (a), before starting the exchange of personal electronic health data. The authorisation shall be based on: (a) a test result without critical findings pursuant to Article 8(4); (b) a compliance check result without critical findings pursuant to Article 8(4); (c) action plans referred to in Article 8(5).

Authorisation to upgrade and to continue the exchange of personal electronic health data following an upgrade

Article 11

Open ↗

1.   Each national contact point for digital health shall obtain authorisation referred to in Article 7(1), point (b), no later than one month before the end of the timeline referred to in Article 6(3). The authorisation shall be based on a technical test result without critical findings referred to in Article 8(4). 2.   Where a national contact point for digital health is not granted the authorisation referred to in paragraph 1, the steering group shall adopt mitigation measures, which may include the temporary suspension of the exchange of personal electronic health data. 3.   Where the exchange of personal electronic health data is suspended in accordance with paragraph 2, the national contact point for digital health shall take the following measures: (a) address the findings that caused the suspension; (b) obtain authorisation referred to in Article 7(1), point (b); (c) implement an upgrade to the latest major release and restore the exchange of personal electronic health data.

Continuing the exchange of personal electronic health data following an operational compliance check

Article 12

Open ↗

1.   Each national contact point for digital health shall obtain authorisation referred to in Article 7(1), point (c), no later than two months after receiving a compliance check result referred to in Article 8(4). The authorisation shall be based on a compliance check result without critical findings. 2.   Where a national contact point for digital health is not granted authorisation referred to in paragraph 1, the steering group shall adopt mitigation measures, which may include the temporary suspension of the exchange of personal electronic health data. 3.   When the exchange of personal electronic health data is suspended in accordance with paragraph 2, the national contact point for digital health shall take the following measures: (a) close findings causing the suspension; (b) obtain authorisation referred to in Article 7(1), point (c); (c) restore the exchange of personal electronic health data.

Significant incidents

Article 13

Open ↗

1.   A national contact point for digital health, or the Commission as relevant, shall notify the chair of the steering group, the Commission and any relevant affected national contact points for digital health as soon as possible, and in any event within 24 hours of becoming aware of a significant incident. 2.   Following notification referred to in paragraph 1, or on its own initiative, the Commission, in agreement with the chair of the steering group, shall address the significant incident. 3.   The national contact point for digital health whose cross-border exchange of personal electronic health data is affected by the significant incident, and the steering group if necessary, shall take the necessary measures to mitigate that incident. Such measures may include the temporary suspension of the exchange of personal electronic health data. 4.   The national contact point for digital health concerned shall, following approval of the steering group, restore the suspended cross-border exchange of personal electronic health data as soon as possible following resolution of the significant incident. 5.   The national contact point for digital health whose cross-border exchange of personal electronic health data was affected by the significant incident or the Commission, if a service referred to in Article 3(1) was affected by the significant incident, shall report to the steering group no later than one month after submission of the notification referred to in paragraph 1. This shall include at least the following: (a) a detailed description of the significant incident, including its severity and impact; (b) the type of threat or root cause that is likely to have triggered the significant incident; (c) the mitigation measures already taken and still being taken.

Processing of personal data in MyHealth@EU

Article 14

Open ↗

The processing of personal data in MyHealth@EU shall be limited to: (a) the priority categories of personal electronic health data for primary use referred to in Article 14(1), first subparagraph, of Regulation (EU) 2025/327; (b) additional categories of personal electronic health data for primary use referred to in Article 14(1), third subparagraph, of Regulation (EU) 2025/327; (c) personal data necessary to manage MyHealth@EU, including management of the help desk.

Responsibilities of the national contact points for digital health as joint controllers

Article 15

Open ↗

1.   In their capacity as joint controllers, the national contact points for digital health shall have the responsibilities listed below. (a) They shall set up a contact point with a functional mailbox for communication between the joint controllers and between the joint controllers and the processor. (b) They shall coordinate among each other in the steering group to provide coordinated instructions to the Commission as a processor. (c) They shall send any necessary instructions to the Commission, as the processor, through the steering group, as agreed with the other joint controllers in the group. (d) They shall be responsible for informing data subjects about the processing of personal data in MyHealth@EU in accordance with Articles 13 and 14 of Regulation (EU) 2016/679. (e) They shall address data subject requests for exercise of data subject rights as provided for by Regulation (EU) 2016/679. Where a joint controller receives a request that falls outside its responsibilities for MyHealth@EU, it shall forward the request to the relevant joint controller and inform the data subject. (f) They shall take all appropriate organisational, physical and logical security measures to ensure that each national contact point for digital health operates securely and document these measures. These measures shall ensure that: (i) persons authorised to process personal data exchanged through MyHealth@EU are under an appropriate statutory obligation of confidentiality or have committed themselves to confidentiality; (ii) exchanges of personal data through MyHealth@EU are logged systematically in order to keep a record of personal data exchanges, including the identity of actors involved, the categories of personal data and the purposes for which they were exchanged. (g) They shall assist each other in identifying and handling any incidents, including personal data breaches, linked to processing in MyHealth@EU. In particular, the joint controllers shall notify each other and the Commission of: (i) any risks to the security of the personal data processed in MyHealth@EU; (ii) any security incidents linked to personal data processing operations in MyHealth@EU; (iii) any personal data breach, the likely consequences of the breach and the assessment of the risk to the rights and freedoms of natural persons, and any measures taken to address the breach and mitigate the risk to those rights and freedoms; (iv) any breach of technical or organisational safeguards of the processing operations in MyHealth@EU. (h) They shall communicate any personal data breaches with regard to processing operations in MyHealth@EU to the competent data protection supervisory authorities and, where required, to data subjects, in accordance with Articles 33 and 34 of Regulation (EU) 2016/679. (i) They shall cooperate in carrying out assessments of the impact of the envisaged processing operations, in accordance with Article 35 of Regulation (EU) 2016/679, where necessary. 2.   Where a joint controller, in order to comply with its obligations laid down in Articles 33 and 34 of Regulation (EU) 2016/679, needs information from another joint controller, it shall send a specific request to the relevant functional mailbox referred to in paragraph (1), point (a). The other joint controller shall make best efforts to provide such information.

Responsibilities of the Commission as processor

Article 16

Open ↗

In its capacity as processor, the Commission shall have the responsibilities listed below. The Commission may engage third parties as sub-processors to fulfil these responsibilities. (a) It shall set up and maintain a secure and reliable communication service for national contact points for digital health participating in MyHealth@EU (‘central secure communication service’). (b) It shall configure the central secure communication service so as to allow national contact points for digital health to exchange information securely, reliably and efficiently. (c) It shall take measures to facilitate interoperability and communication between the central secure communication service and the joint controllers of MyHealth@EU. (d) It shall process personal data only on instructions from the joint controllers of MyHealth@EU, unless required to do so by law to which it is subject. In that case, the Commission shall inform the controller of that legal requirement before processing, unless that law prohibits this on important grounds of public interest. The Commission shall immediately inform the joint controllers if, in its opinion, instructions given infringe applicable data protection provisions. (e) It shall put in place the necessary measures to ensure a level of security of personal data processed in the secure communication service appropriate to the risks. These measures shall be documented in a security plan, which shall be kept up to date. The measures shall include: (i) putting in place a risk assessment procedure to identify and estimate potential threats to the system; (ii) ensuring that persons authorised to process personal data are under an appropriate statutory obligation of confidentiality, such as that laid down in Article 17 of the Staff Regulations of officials of the European Communities, laid down in Council Regulation (EEC, Euratom, ECSC) No 259/68  ( 9 ) , or have committed themselves to confidentiality; (iii) taking adequate measures to ensure that its staff, and contractors, understand their responsibilities regarding information security and the protection of sensitive non-classified information. (iv) implementing technical and organisational security measures to prevent unauthorised access to personal data; (v) ensuring the integrity of information sent through the secure communication service; (vi) implementing, whenever necessary, measures to block unauthorised access to the secure communication service from the domain of national contact points for digital health; (vii) ensuring that data transported within the central secure communication service are encrypted; (viii) taking appropriate physical security measures, including: 1. controlling access to the facilities and maintaining a visitor register for tracing purposes; 2. ensuring that external persons granted access to premises are escorted by duly authorised staff. (f) It shall implement a change management procedure and keep the joint controllers informed of any changes that may affect communication with other national infrastructures or the security of those infrastructures. (g) It shall monitor in real time the performance of all components of its secure communication service, produce regular statistics and keep records. (h) It shall implement audit and review procedures in order to: (i) check correspondence between the implemented security measures and the security plan referred to in point (e); (ii) control on a regular basis the integrity of system files, security parameters and authorisation granted; (iii) monitor to detect security breaches; (iv) implement changes to mitigate existing security weaknesses; (v) lay down a security incident management procedure setting out the reporting and escalation scheme; (vi) inform the relevant joint controllers. (i) It shall publish on its website patient information notices about the processing of personal data in MyHealth@EU, after their content has been agreed by the joint controllers. (j) It shall support the joint controllers by providing information on the secure communication service of MyHealth@EU, in order to implement the obligations in Articles 32 to 36 of Regulation (EU) 2016/679. (k) Following termination of the data exchange, it shall delete all personal data processed on behalf of a controller and certify to the controller that it has done so, unless applicable law requires storage of the personal data. (l) It shall provide the joint controllers with all information necessary to demonstrate compliance with its obligations as processor and allow for, including at the request of controllers, and contribute to the performance of independent audits, including inspections, and reviews on security measures, subject to conditions that comply with Protocol (No 7) to the Treaty on the Functioning of the European Union on the privileges and immunities of the European Union.

Security of MyHealth@EU

Article 17

Open ↗

The Commission shall ensure the security of MyHealth@EU, in accordance with Decision (EU, Euratom) 2017/46.

Transitional measures

Article 18

Open ↗

National contact points for e-Health that have exchanged personal electronic health data through the eHealth Digital Service Infrastructure for Cross-Border eHealth Information Services pursuant to Implementing Decision 2019/1765 before 26 March 2029 and which have been designated as national contact points for digital health under Article 23(2) of Regulation (EU) 2025/327 may continue to exchange such data in the framework of MyHealth@EU and shall be deemed to comply with the authorisation requirements to start the exchange of personal electronic health data laid down in this Regulation.

Entry into force and date of application

Article 19

Open ↗

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union . It shall apply from 26 March 2027.

Other acts of the same type
Commission Implementing Regulation (EU) 2021/790 of 10 May 2021 entering a name in the register of protected designations of origin and protected geographical indications (‘Pesca di Delia’ (PGI))Commission Implementing Regulation (EU) 2021/791 of 10 May 2021 approving non-minor amendments to the specification for a name entered in the register of protected designations of origin and protected geographical indications (‘Aischgründer Karpfen’ (PGI))Commission Delegated Regulation (EU) 2021/1204 of 10 May 2021 amending Delegated Regulation (EU) 2019/856 as regards the application and selection procedures under the Innovation FundCommission Implementing Regulation (EU) 2021/758 of 7 May 2021 on the status of certain products as feed additives within the scope of Regulation (EC) No 1831/2003 of the European Parliament and of the Council and on the withdrawal from the market of certain feed additives (Text with EEA relevance)Commission Implementing Regulation (EU) 2021/759 of 7 May 2021 amending Implementing Regulation (EU) 2019/2072 as regards the exceptions from the requirement of a plant passport, the status of Italy, Ireland, Lithuania, Slovenia and Slovakia or certain areas thereof as protected zones, and the reference to a protected zone in PortugalCommission Implementing Regulation (EU) 2021/760 of 7 May 2021 amending Implementing Regulations (EU) 2020/761 and (EU) 2020/1988 as regards the management system of some tariff quotas with licences and repealing Implementing Regulation (EU) 2020/991Commission Implementing Regulation (EU) 2021/761 of 7 May 2021 amending Annexes I to IV to Implementing Regulation (EU) 2017/717 as regards the model forms of zootechnical certificates for breeding animals and their germinal products (Text with EEA relevance)Commission Delegated Regulation (EU) 2021/1189 of 7 May 2021 supplementing Regulation (EU) 2018/848 of the European Parliament and of the Council as regards the production and marketing of plant reproductive material of organic heterogeneous material of particular genera or species (Text with EEA relevance)Council Implementing Regulation (EU) 2021/743 of 6 May 2021 implementing Regulation (EU) No 36/2012 concerning restrictive measures in view of the situation in SyriaCommission Implementing Regulation (EU) 2021/744 of 6 May 2021 laying down technical information for the calculation of technical provisions and basic own funds for reporting with reference dates from 31 March 2021 until 29 June 2021 in accordance with Directive 2009/138/EC of the European Parliament and of the Council on the taking-up and pursuit of the business of Insurance and Reinsurance (Text with EEA relevance)Commission Implementing Regulation (EU) 2021/745 of 6 May 2021 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances aluminium ammonium sulphate, aluminium silicate, beflubutamid, benthiavalicarb, bifenazate, boscalid, calcium carbonate, captan, carbon dioxide, cymoxanil, dimethomorph, ethephon, extract from tea tree, famoxadone, fat distilation residues, fatty acids C7 to C20, flumioxazine, fluoxastrobin, flurochloridone, folpet, formetanate, gibberellic acid, gibberellins, heptamaloxyloglucan, hydrolysed proteins, iron sulphate, metazachlor, metribuzin, milbemectin, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, plant oils/rape seed oil, potassium hydrogen carbonate, propamocarb, prothioconazole, quartz sand, fish oil, repellents by smell of animal or plant origin/ sheep fat, S-metolachlor, Straight Chain Lepidopteran Pheromones, tebuconazole and urea (Text with EEA relevance)Commission Delegated Regulation (EU) 2021/962 of 6 May 2021 extending the transitional period referred to in Article 89(1), first subparagraph, of Regulation (EU) No 648/2012 of the European Parliament and of the Council (Text with EEA relevance)

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next